Tilray Target of Unusually Large Options Trading (NASDAQ:TLRY)

Tilray Inc (NASDAQ:TLRY - Get Free Report) was the target of some unusual options trading on Friday. Traders bought 72,984 call options on the stock. This is an increase of 61% compared to the average daily volume of 45,257 call options.

Tilray Price Performance

NASDAQ:TLRY traded down $0.14 during mid-day trading on Friday, hitting $1.23. 60,630,128 shares of the company's stock traded hands, compared to its average volume of 51,427,516. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.57 and a current ratio of 2.47. The company has a market cap of $1.11 billion, a PE ratio of -4.56 and a beta of 2.08. The firm's 50 day simple moving average is $1.37 and its 200 day simple moving average is $1.62. Tilray has a 1 year low of $1.14 and a 1 year high of $2.97.

Tilray (NASDAQ:TLRY - Get Free Report) last issued its quarterly earnings data on Friday, January 10th. The company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.07). Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The business had revenue of $210.90 million for the quarter, compared to analysts' expectations of $216.34 million. Tilray's revenue for the quarter was up 8.7% on a year-over-year basis. Sell-side analysts expect that Tilray will post -0.14 EPS for the current year.

Analysts Set New Price Targets

Separately, Roth Mkm dropped their price objective on Tilray from $2.00 to $1.75 and set a "neutral" rating for the company in a research note on Friday, October 11th.

Insider Activity

In related news, CFO Carl A. Merton bought 26,000 shares of the company's stock in a transaction on Friday, November 15th. The stock was bought at an average cost of $1.36 per share, with a total value of $35,360.00. Following the completion of the acquisition, the chief financial officer now owns 26,000 shares in the company, valued at approximately $35,360. This represents a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.87% of the company's stock.

Institutional Trading of Tilray

Several institutional investors and hedge funds have recently made changes to their positions in TLRY. Ferguson Wellman Capital Management Inc. purchased a new stake in Tilray during the 3rd quarter worth about $26,000. Vanguard Capital Wealth Advisors acquired a new position in shares of Tilray in the second quarter valued at approximately $34,000. Vista Capital Partners Inc. acquired a new position in Tilray in the third quarter valued at $42,000. International Assets Investment Management LLC lifted its position in Tilray by 335.3% during the third quarter. International Assets Investment Management LLC now owns 23,639 shares of the company's stock worth $42,000 after buying an additional 18,208 shares during the period. Finally, Capital Management Associates Inc acquired a new stake in Tilray in the 3rd quarter worth about $45,000. 9.35% of the stock is currently owned by hedge funds and other institutional investors.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.